Full Text View
Tabular View
No Study Results Posted
Related Studies
Preoperative Bevacizumab for Vitreous Hemorrhage (IBEVI)
This study has been completed.
Study NCT00596297   Information provided by University of Sao Paulo
First Received: January 4, 2008   Last Updated: October 2, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Retinopathy
Vitreous Hemorrhage
Additional conditions recognized in this trial
Hemorrhage
Retinal Diseases
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Endocrine System Diseases
Eye Diseases
Eye Hemorrhage
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
bevacizumab
pars plana vitrectomy
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Sao Paulo


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services